Kurt C. Gunter
Chief Tech/Sci/R&D Officer at INOZYME PHARMA, INC.
Profile
Kurt C.
Gunter is currently the President of the International Society for Cellular Therapy and the Chief Medical Officer & Senior Vice President at Inozyme Pharma, Inc. He previously held positions such as Director-Stem Cell Processing & Hematology at Children's National Hospital, Deputy Director-Cell & Gene Therapy Division at the Center for Biologics Evaluation & Research, Vice President-Clinical & Regulatory at Transkaryotic Therapies, Inc., Senior Vice President-Regulatory Affairs at ViaCell, Inc., Principal at Hospira, Inc., Chief Medical Officer-Cell Therapy at Athenex, Inc., Medical Officer at the US Food & Drug Administration, and Chief Medical Officer at Kuur Therapeutics Ltd.
Gunter received his undergraduate degree from Stanford University and his doctorate from the University of Kansas Medical School.
Kurt C. Gunter active positions
Companies | Position | Start |
---|---|---|
INOZYME PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2022-06-06 |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | President | - |
Former positions of Kurt C. Gunter
Companies | Position | End |
---|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Children's National Hospital (District of Columbia)
Children's National Hospital (District of Columbia) Hospital/Nursing ManagementHealth Services Children's Hospital is a non-profit organization which engages in the provision of healthcare services. It offers pediatric and adolescent services, cardiac surgery, colorectal program, neurosurgery, oncology, and orthopedic surgery and sports medicine. The company was founded in 1870 and is headquartered in Washington, DC. | Corporate Officer/Principal | 1995-12-31 |
ATHENEXPAR | General Counsel | - |
HOSPIRA, INC. | Corporate Officer/Principal | - |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Chief Tech/Sci/R&D Officer | - |
Training of Kurt C. Gunter
Stanford University | Undergraduate Degree |
University of Kansas Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INOZYME PHARMA, INC. | Health Technology |
Private companies | 9 |
---|---|
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Health Technology |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Center for Biologics Evaluation & Research engages in the regulation of biological and related products. Its scope includes blood, vaccines, allergenics, tissues, and cellular and gene therapies. The company is headquartered in Silver Spring, MD. | Commercial Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Children's National Hospital (District of Columbia)
Children's National Hospital (District of Columbia) Hospital/Nursing ManagementHealth Services Children's Hospital is a non-profit organization which engages in the provision of healthcare services. It offers pediatric and adolescent services, cardiac surgery, colorectal program, neurosurgery, oncology, and orthopedic surgery and sports medicine. The company was founded in 1870 and is headquartered in Washington, DC. | Health Services |
Athenex, Inc.
Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- Kurt C. Gunter